论文部分内容阅读
目的:观察慢性乙肝患者采用中西医结合治疗的临床疗效。方法:分析慢性乙肝患者84例的临床资料,随机分为两组,对照组采取恩替卡韦分散片治疗,治疗组在对照组的基础上联合慢肝颗粒治疗,比较两者的各项指标。结果:治疗结束后,治疗组患者在HA、PCⅢ、LN、ALT等检查方面均明显低于对照组(P<0.05)。两组患者在e抗原转阴率、HBVDNA转阴率方面无明显差异(P>0.05)。结论:采用中西医结合治疗慢性乙肝能使患者肝脏炎症得到明显控制,显著减轻患者肝纤维化程度,防止肝硬化的发生,临床疗效明显,值得临床推广应用。
Objective: To observe the clinical efficacy of combined treatment of traditional Chinese and western medicine in chronic hepatitis B patients. Methods: The clinical data of 84 patients with chronic hepatitis B were analyzed and randomly divided into two groups. The control group was treated with entecavir dispersible tablets. The treatment group was treated with slow liver granules on the basis of the control group, and the indexes of the two groups were compared. Results: After the treatment, the patients in the treatment group were significantly lower than those in the control group (P <0.05) in the examination of HA, PC Ⅲ, LN and ALT. There was no significant difference between the two groups in e antigen negative rate and HBVDNA negative rate (P> 0.05). Conclusion: The treatment of chronic hepatitis B with integrated traditional Chinese and western medicine can make patients’ liver inflammation significantly controlled, significantly reduce the degree of liver fibrosis and prevent the occurrence of cirrhosis. The clinical curative effect is obvious and worthy of clinical application.